Posts Tagged Wilmot Cancer Institute

At a May meeting, the University Board of Trustees elected two new members, and recognized three members on becoming life trustees.

The new imaging system developed by Michael Giacomelli, an assistant professor of biomedical engineering and of optics, uses two-photon fluorescence microscopy (TPFM).

Looking at and discussing curated art, including works from the University’s Memorial Art Gallery collection, helped calm a group of cancer patients.

An internal funding program, plus the close proximity of the University’s engineering and medical facilities, promotes progress in a potential treatment for acute myeloid leukemia.

Rochester biomedical engineer Michael Giacomelli is pursuing a quicker way to detect skin cancer.

A Wilmot Cancer Institute study of more than 90 families and caregivers looked for common threads about their loved one’s final transition from active treatment to death and dying.

Thu Le, professor of medicine; Paula Vertino, professor of biomedical genetics; and David Herrmann, professor of neurology; have each been recently appointed to named professorships.

A breakthrough study from Rochester’s Wilmot Cancer Institute gives researchers hope that new gene-targeted therapies could improve survival rates for acute myeloid leukemia, which have not budged in years.

Some Wilmot Cancer Institute patients with advanced melanoma may have longer disease-free survival thanks to new drug treatment options tested by Rochester researchers.

Wilmot Cancer Institute scientists have discovered that a three-drug combination can simultaneously target the cancer cells as well as the other harmful, inflammatory cells within the tumor.